Schedule 13D ownership disclosure

Ra Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 74933V108

Event date: 2018-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,135,084
Percent of class
10.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-009568
Form type
SC 13D/A
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Feb 16, 2018
Reporting period
Feb 14, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub